Linagliptin is associated to increased treatment adherence and satisfaction in elderly outpatients with diabetes and advanced chronic kidney disease

The treatment of diabetes in frail elderly patients with decreased renal function is challenging and insufficiently supported by evidence. Due to their good tolerability and low hypoglycemic risk, oral dipeptidyl peptidase- 4 (DPP-4) inhibitors have emerged as a reasonable option for glycemic contro...

Full description

Bibliographic Details
Main Authors: Franco Gregorio, Eleonora Guerrini, Daniele Gregorio, Giorgio Montecchiani
Format: Article
Language:English
Published: PAGEPress Publications 2016-11-01
Series:Geriatric Care
Subjects:
Online Access:http://www.pagepressjournals.org/index.php/gc/article/view/6220